Pacific biosciences of california stock.

11 analysts have issued 1 year price objectives for Pacific Biosciences of California's stock. Their PACB share price targets range from $8.00 to $17.00. On average, they predict the company's stock price to reach $11.80 in the next year. This suggests a possible upside of 38.0% from the stock's current price.

Pacific biosciences of california stock. Things To Know About Pacific biosciences of california stock.

Pacific Biosciences of California Inc (NASDAQ: PACB) has seen a rise in its stock price by 10.74 in relation to its previous close of 6.52. However, the company has experienced a 1.55% gain in its stock price over the last five trading sessions. Zacks Investment Research reported 2023-10-31 that PacBio (PACB) witnesses strong revenue …Pacific Biosciences Of California reported $68.26M in Stock for its fiscal quarter ending in September of 2023. Data for Pacific Biosciences Of California ...Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...Pacific Biosciences of California Inc’s price is currently down 2.39% so far this month. During the month of September, Pacific Biosciences of California Inc’s stock price has reached a high of $11.96 and a low of $10.14. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low as $4.97.Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...

Nov 27, 2023 · Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings Preview Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend …Pacific Biosciences of California, Inc. 1305 O’Brien Drive Menlo Park, CA 94025 United States 650 521 8000 https://www.pacb.com Sector(s) : Healthcare Industry : Medical Devices Full Time ...

May 25, 2021 · Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.

Pacific Biosciences of California's (PACB) CEO Mike Hunkapiller on Q4 2015 Results - Earnings Call Transcript SA Transcripts Wed, Feb. 03, 2016 Pacific Biosciences of California (PACB) Q4 2015 ...These 9 analysts have an average price target of $11.22 versus the current price of Pacific Biosciences at $7.2, implying upside. Below is a summary of how these 9 analysts rated Pacific ...A high-level overview of Pacific Biosciences of California, Inc. (PACB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Pacific Biosciences of California, Inc. ("PacBio") (NASDAQ: PACB) today announced that it has entered into a privately negotiated exchange agreement with a holder of PacBio's outstanding 1.50% ...

PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...

Dec 4, 2023 · Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million.

Pacific Biosciences of California Inc stock has a Value Score of 8, Growth Score of 57 and Quality Score of 12. Comparing Inmode Ltd and Pacific Biosciences of California Inc’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset ...١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis. Institutional investors purchased a net $7.8 million shares of PACB during the quarter ended June 2019 and now own 98.90% of the total shares outstanding. This ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Pacific Biosciences of California share forecasts, stock quote and buy / sell signals below. According to present data Pacific Biosciences of California's PACB shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Apr 11, 2023 · Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on August 02,2023. Pacific Biosciences (PACB) delivered earnings and revenue ... Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock …

Get Pacific Biosciences of California (PACB) share price today, stock analysis, price valuation, performance, fundamentals, market cap, shareholding, ...Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.Pacific Biosciences of California (PACB) Q4 2021 Earnings Call Transcript PACB earnings call for the period ending December 31, 2021. Motley Fool Transcribing | Feb 16, 2022Of course Pacific Biosciences of California may not be the best stock to buy.So you may wish to see this free collection of growth stocks.. Please note, the market returns quoted in this article ...

View Pacific Biosciences of California, Inc PACB investment & stock information. Get the latest Pacific Biosciences of California, Inc PACB detailed stock quotes, stock data, Real-Time ECN, charts ...

The share float percentage for the stock currently stands at 98.68%. There are 96.98% institutions holding the Pacific Biosciences of California Inc stock share, with ARK Investment Management, LLC the top institutional holder. As of Sep 29, 2023, the company held 11.15% of the shares, roughly 29.82 million PACB shares worth $247.68 …April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ...View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ.Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsfinance.yahoo.com - October 6 at 3:53 PM. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $162,529.08 in Stock. marketbeat.com - September 29 at 8:19 PM. Bernstein Initiates Coverage of Pacific Biosciences of California (PACB) with Outperform Recommendation. msn.com - September 28 at 11:07 …Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.

Pacific Biosciences of California Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 8.02. Negative dynamics for Pacific Biosciences of California shares will prevail with possible volatility of 5.469%. Pessimistic target level: 7.80.

٢١‏/٠٩‏/٢٠٢٣ ... In fact, the recent sale by Christian O. Henry was the biggest sale of Pacific Biosciences of California shares made by an insider individual in ...

MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Sep 18, 2023 · One such stock that merits attention is Pacific Biosciences of California Inc (NASDAQ:PACB). The stock, which is currently priced at 10.06, recorded a loss of 3.5% in a day and a 3-month decrease ... The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Find the latest Pacific Biosciences of California, Inc. (PACB) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California …Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.Nov 22, 2023 · The Pacific Biosciences of California stock prediction results are shown below and presented as a graph, table and text information. Pacific Biosciences of California stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Pacific Biosciences of California analysts is $. Today ...

US Stock MarketDetailed Quotes. PACB Pacific Biosciences of California. Close 11/13 16:00 ET. 6.440. -0.080 -1.23%. High 6.525. Low 6.175. Volume4.80M. Post ...The firm now holds 59,626 shares of the biotechnology company’s stock, after selling 59,343 shares in the quarter. According to financial data as of the end of the reporting period, these holdings were valued at $793,000. Pacific Biosciences of California is a renowned biotechnology company that specializes in genetic sequencing …Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD.Instagram:https://instagram. bicentennial quaterstop 100 workers' compensation insurance companiesfdvv dividendfalaballea Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Nov 24, 2023 · Get a real-time Pacific Biosciences of California, Inc. (PACB) stock price quote with breaking news, financials, statistics, charts and more. t drive revieweog ticker ١٦‏/٠٨‏/٢٠٢٣ ... Why Pacific Biosciences of California Inc's (PACB) Stock Is Down 4.55% ... One of the most dreaded feelings for an investor is when the stock they ...Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago. best low cost stocks The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.٠٧‏/٠٨‏/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...The Pacific Biosciences of California stock prediction for 2025 is currently $ 21.57, assuming that Pacific Biosciences of California shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 157.52% increase in the PACB stock price.